These data together demonstrate that the enhancement of FXYD6 is closely related with the increased migration and proliferation of HCC cells, which is dependent on the activation of Src or ERK, the downstream signaling components of Na+/K+-ATPase. Here, FXYD6 is linked to hepatocellular carcinoma.